NCT02684851View on ClinicalTrials.gov

The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 25, 2016

Study Completion Date

July 25, 2017

Conditions
Acetabular Fractures
Interventions
DRUG

Tranexamic Acid

Tranexamic acid: anti-fibrinolytic agents

DRUG

Placebo

Placebo

Trial Locations (2)

28205

Carolinas Medical Center, Charlotte

65212

University of Missouri, Columbia

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT02684851 - The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery | Biotech Hunter | Biotech Hunter